Ionis Pharmaceuticals in (ions 0 04/01/26)
13F holders, Q1 2025 (March 31)6holders
0new positions
0sold out
$0.98avg. 13F price*
At the end of Q1 2025, 6 institutions reported holding Ionis Pharmaceuticals in (ions 0 04/01/26) in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holders were BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($491K), Bank of New York Mellon Corp ($297K) and Sonora Investment Management Group, LLC ($157K).
- Company
- Ionis Pharmaceuticals in (ions 0 04/01/26)
- CUSIP
- 462222AD2
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 4,000 shares bought and 1 shares sold, net +3,999 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Reduce 0.0% | 499,999 | $491K |
| Bank of New York Mellon Corp | 0.00% | No change | 300,000 | $297K |
| Sonora Investment Management Group, LLC | 0.01% | No change | 160,000 | $157K |
| Oppenheimer Asset Management Inc. | 0.00% | Add +3.3% | 93,000 | $91K |
| Boussard & Gavaudan Investment Management LLP | 0.02% | No change | 54,910 | $54K |
| Stephens Inc. | 0.00% | Add +4.3% | 24,000 | $24K |
"% of holder's portfolio" is IONIS PHARMACEUTICALS IN (IONS 0 04/01/26)'s weight in each manager's 13F, not the share of Ionis Pharmaceuticals in (ions 0 04/01/26) the manager owns.